{"schema_version":"secwatch.filing_event.v1","accession":"0001562762-25-000114","form_type":"8-K","ticker":"GMED","cik":"0001237831","company_name":"GLOBUS MEDICAL INC","filed_at":"2025-05-08T23:59:59+00:00","discovered_at":"2026-05-14T18:02:47.761111+00:00","generated_at":"2026-05-22T03:19:42.856207+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Globus Medical Q1 revenue down 1.4% to $598.1M; cuts non-GAAP EPS guidance to $3.00-$3.30","bullets":["GAAP net income $75.5M; GAAP diluted EPS $0.54 vs ($0.05) a year ago.","Non-GAAP diluted EPS $0.68, up 8.5% YoY; prior guidance $3.10-$3.40 now $3.00-$3.30.","Revenue fell 1.4% as-reported (0.8% constant currency); US up 0.2%, Intl down 7.7% as-reported.","Paid off remaining $450M debt from NuVasive merger; Q1 free cash flow $141.2M.","Company cites softer Enabling Technology deals, supply chain disruption, and timing of intl orders."],"urls":{"canonical":"https://secwatch.observer/filing/0001562762-25-000114","json":"https://secwatch.observer/filing/0001562762-25-000114.json","markdown":"https://secwatch.observer/filing/0001562762-25-000114.md","text":"https://secwatch.observer/filing/0001562762-25-000114.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1237831/000156276225000114/0001562762-25-000114-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1237831/000156276225000114/gmed-20250508x8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-22T03:19:42.856207+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}